Literature DB >> 26880821

Perianal melanoma with a BRAF gene mutation in a young Portuguese Roma native.

Jennifer Tan1.   

Abstract

A case of a young man diagnosed with perianal nodular melanoma with a gene mutation, accompanied by regional and pulmonary metastases on initial presentation, and later on with hepatic and bone involvement, is presented. The patient underwent wide local excision but was unresponsive to dacarbazine. Targeted therapy with vemurafenib had shown clinical improvement for a 5-month duration until he showed signs of disease progression. Just after the shift of adjuvant therapy to ipilimumab, he was diagnosed with multiple cerebral metastases that eventually led to his demise 6 months after initiation of vemurafenib, having had a 12-month survival period from the time of initial melanoma diagnosis. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26880821      PMCID: PMC5483573          DOI: 10.1136/bcr-2015-212772

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  24 in total

1.  Improved survival with MEK inhibition in BRAF-mutated melanoma.

Authors:  Keith T Flaherty; Caroline Robert; Peter Hersey; Paul Nathan; Claus Garbe; Mohammed Milhem; Lev V Demidov; Jessica C Hassel; Piotr Rutkowski; Peter Mohr; Reinhard Dummer; Uwe Trefzer; James M G Larkin; Jochen Utikal; Brigitte Dreno; Marta Nyakas; Mark R Middleton; Jürgen C Becker; Michelle Casey; Laurie J Sherman; Frank S Wu; Daniele Ouellet; Anne-Marie Martin; Kiran Patel; Dirk Schadendorf
Journal:  N Engl J Med       Date:  2012-06-04       Impact factor: 91.245

2.  Improved overall survival in melanoma with combined dabrafenib and trametinib.

Authors:  Caroline Robert; Boguslawa Karaszewska; Jacob Schachter; Piotr Rutkowski; Andrzej Mackiewicz; Daniil Stroiakovski; Michael Lichinitser; Reinhard Dummer; Florent Grange; Laurent Mortier; Vanna Chiarion-Sileni; Kamil Drucis; Ivana Krajsova; Axel Hauschild; Paul Lorigan; Pascal Wolter; Georgina V Long; Keith Flaherty; Paul Nathan; Antoni Ribas; Anne-Marie Martin; Peng Sun; Wendy Crist; Jeff Legos; Stephen D Rubin; Shonda M Little; Dirk Schadendorf
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245

Review 3.  Primary malignant melanoma at unusual sites: an institutional experience with review of literature.

Authors:  Prasenjit Das; Narender Kumar; Arvind Ahuja; Ayushi Jain; Ruma Ray; Chitra Sarkar; Siddhartha Datta Gupta
Journal:  Melanoma Res       Date:  2010-06       Impact factor: 3.599

4.  Changing epidemiology of anorectal melanoma.

Authors:  B Cagir; M H Whiteford; A Topham; J Rakinic; R D Fry
Journal:  Dis Colon Rectum       Date:  1999-09       Impact factor: 4.585

5.  Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.

Authors:  Jeffrey A Sosman; Kevin B Kim; Lynn Schuchter; Rene Gonzalez; Anna C Pavlick; Jeffrey S Weber; Grant A McArthur; Thomas E Hutson; Stergios J Moschos; Keith T Flaherty; Peter Hersey; Richard Kefford; Donald Lawrence; Igor Puzanov; Karl D Lewis; Ravi K Amaravadi; Bartosz Chmielowski; H Jeffrey Lawrence; Yu Shyr; Fei Ye; Jiang Li; Keith B Nolop; Richard J Lee; Andrew K Joe; Antoni Ribas
Journal:  N Engl J Med       Date:  2012-02-23       Impact factor: 91.245

Review 6.  [Melanoma of the anal margin].

Authors:  B Lerondeau; F Granel-Brocard; J-F Cuny; J Specty-Ferry; L Bressler; A Barbaud; J-L Schmutz
Journal:  Ann Dermatol Venereol       Date:  2013-03-26       Impact factor: 0.777

Review 7.  Nivolumab: A Review in Advanced Melanoma.

Authors:  Lesley J Scott
Journal:  Drugs       Date:  2015-08       Impact factor: 9.546

8.  Amelanotic malignant melanoma of the perineum: a case report.

Authors:  M Zamurovic; V Soldo; N Cutura; Z Perisic
Journal:  Eur J Gynaecol Oncol       Date:  2013       Impact factor: 0.196

9.  The role of BRAF V600 mutation in melanoma.

Authors:  Paolo A Ascierto; John M Kirkwood; Jean-Jacques Grob; Ester Simeone; Antonio M Grimaldi; Michele Maio; Giuseppe Palmieri; Alessandro Testori; Francesco M Marincola; Nicola Mozzillo
Journal:  J Transl Med       Date:  2012-07-09       Impact factor: 5.531

Review 10.  The clinical features and optimal treatment of anorectal malignant melanoma.

Authors:  Soomin Nam; Chang Woo Kim; Se Jin Baek; Hyuk Hur; Byung Soh Min; Seung Hyuk Baik; Nam Kyu Kim
Journal:  Ann Surg Treat Res       Date:  2014-08-26       Impact factor: 1.859

View more
  2 in total

1.  Immunotherapy in a rare case of primary pelvic retroperitoneal melanoma.

Authors:  Maria Monica Talag; Mohamed Alsharedi; Nadim Bou Zgheib; Yehuda Lebowicz
Journal:  BMJ Case Rep       Date:  2016-09-13

2.  Diagnostic significance of CK19, galectin-3, CD56, TPO and Ki67 expression and BRAF mutation in papillary thyroid carcinoma.

Authors:  Lihua Huang; Xuming Wang; Xuan Huang; Huawei Gui; Yan Li; Qiongxia Chen; Dongling Liu; Lijiang Liu
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.